Product NDC: | 0093-2058 |
Proprietary Name: | Nifedipine |
Non Proprietary Name: | Nifedipine |
Active Ingredient(s): | 60 mg/1 & nbsp; Nifedipine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-2058 |
Labeler Name: | TEVA PHARMACEUTICALS USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075269 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120507 |
Package NDC: | 0093-2058-55 |
Package Description: | 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-2058-55) |
NDC Code | 0093-2058-55 |
Proprietary Name | Nifedipine |
Package Description | 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-2058-55) |
Product NDC | 0093-2058 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nifedipine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120507 |
Marketing Category Name | ANDA |
Labeler Name | TEVA PHARMACEUTICALS USA |
Substance Name | NIFEDIPINE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |